Theranostics Using Antibodies and Antibody-Related Therapeutics-Reference-Cited by-同舟云学术

Theranostics Using Antibodies and Antibody-Related Therapeutics

Published:2017-09 Issue:Supplement 2 Volume:58 Page:83S-90S
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Moek Kirsten L.,Giesen Danique,Kok Iris C.,de Groot Derk Jan A.,Jalving Mathilde,Fehrmann Rudolf S.N.,Lub-de Hooge Marjolijn N.,Brouwers Adrienne H.,de Vries Elisabeth G.E.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference44 articles.

1. Loibl S Gianni L . HER2-positive breast cancer. Lancet. December 6, 2016 [Epub ahead of print].

2. Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

3. Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatment;El-Osta;Onco Targets Ther.,2016

4. Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy;Eggermont;N Engl J Med.,2016

5. Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Target engagement of an anti-MT1-MMP antibody for triple-negative breast cancer PET imaging and beta therapy;Nuclear Medicine and Biology;2024-09

2. Zirconium 89 and Copper 64 for ImmunoPET: From Antibody Bioconjugation and Radiolabeling to Molecular Imaging;Pharmaceutics;2024-06-30

3. Can current preclinical strategies for radiopharmaceutical development meet the needs of targeted alpha therapy?;European Journal of Nuclear Medicine and Molecular Imaging;2024-04-27

4. Approaches to Reducing Normal Tissue Radiation from Radiolabeled Antibodies;Pharmaceuticals;2024-04-16

5. ImmunoPET imaging of Trop2 in patients with solid tumours;EMBO Molecular Medicine;2024-04-02